Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial

被引：6
|
作者：
Piccolo, Raffaele [1 ]
Heg, Dik [1 ]
Franzone, Anna [1 ]
Roffi, Marco [1 ]
Tuller, David [1 ]
Vuilliomenet, Andre [1 ]
Muller, Olivier [1 ]
Cook, Stephane [1 ]
Weilenmann, Daniel [1 ]
Kaiser, Christoph [1 ]
Jamshidi, Peiman [1 ]
Iglesias, Juan F. [1 ]
Windecker, Stephan [1 ]
Pilgrim, Thomas [1 ]
机构：
[1] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2016年 / 9卷 / 09期
关键词：
D O I：
10.1016/j.jcin.2016.02.044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：981 / 983
页数：5
相关论文
共 50 条
  • [1] Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial
    Iglesias, Juan F.
    Heg, Dik
    Roffi, Marco
    Degrauwe, Sophie
    Tueller, David
    Muller, Olivier
    Brinkert, Miriam
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Cuculi, Florim
    Valgimigli, Marco
    Juni, Peter
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 34 : 3 - 10
  • [2] Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
    Iglesias, Juan F.
    Muller, Olivier
    Heg, Dik
    Roffi, Marco
    Kurz, David J.
    Moarof, Igal
    Weilenmann, Daniel
    Kaiser, Christoph
    Tapponnier, Maxime
    Stortecky, Stefan
    Losdat, Sylvain
    Eeckhout, Eric
    Valgimigli, Marco
    Odutayo, Ayodele
    Zwahlen, Marcel
    Juni, Peter
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. LANCET, 2019, 394 (10205): : 1243 - 1253
  • [3] Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy
    Nader Mankerious
    Rayyan Hemetsberger
    Hussein Traboulsi
    Ralph Toelg
    Mohamed Abdel-Wahab
    Gert Richardt
    Abdelhakim Allali
    [J]. Clinical Research in Cardiology, 2021, 110 : 1574 - 1585
  • [4] Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy
    Mankerious, Nader
    Hemetsberger, Rayyan
    Traboulsi, Hussein
    Toelg, Ralph
    Abdel-Wahab, Mohamed
    Richardt, Gert
    Allali, Abdelhakim
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (10) : 1574 - 1585
  • [5] Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
    Pilgrim, Thomas
    Piccolo, Raffaele
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Khattab, Ahmed A.
    Taniwaki, Masanori
    Rigamonti, Fabio
    Nietlispach, Fabian
    Blochlinger, Stefan
    Wenaweser, Peter
    Juni, Peter
    Windecker, Stephan
    [J]. EUROINTERVENTION, 2016, 12 (11) : E1343 - E1354
  • [6] Long-term outcomes with biodegradable polymer sirolimus- eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial
    Iglesias, Juan F.
    Roffi, Marco
    Losdat, Sylvain
    Muller, Olivier
    Degrauwe, Sophie
    Kurz, David J.
    Haegeli, Laurent
    Weilenmann, Daniel
    Kaiser, Christoph
    Tapponnier, Maxime
    Cook, Stephane
    Cuculi, Florim
    Heg, Dik
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. LANCET, 2023, 402 (10416): : 1979 - 1990
  • [7] Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study
    Parsa, Ehsan
    Saroukhani, Sepideh
    Majlessi, Fereshteh
    Poorhosseini, Hamidreza
    Lofti-Tokaldany, Masoumeh
    Jalali, Arash
    Salarifar, Mojtaba
    Nematipour, Ebrahim
    Alidoosti, Mohammad
    Aghajani, Hassan
    Amirzadegan, Alireza
    Kassaian, Seyed Ebrahim
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2016, 43 (02): : 126 - 130
  • [8] Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
    Pilgrim, Thomas
    Piccolo, Raffaele
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Muller, Olivier
    Moarof, Igal
    Siontis, George C. M.
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Cuculi, Florim
    Hunziker, Lukas
    Eberli, Franz R.
    Juni, Peter
    Windecker, Stephan
    [J]. LANCET, 2018, 392 (10149): : 737 - 746
  • [9] Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial
    Pilgrim, Thomas
    Roffi, Marco
    Tueller, David
    Muller, Olivier
    Vuilliomenet, Andre
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Heg, Dik
    Jueni, Peter
    Windecker, Stephan
    [J]. AMERICAN HEART JOURNAL, 2014, 168 (03) : 256 - 261
  • [10] Everolimus-eluting Versus Sirolimus-eluting Stents in Patients with ST Elevation Myocardial Infarction.
    Kwon, Chang Hee
    Park, Gyung-Min
    Cho, Young-Rak
    Ahn, Jung-Min
    Kim, Won-Jang
    Lee, Jong-Young
    Park, Duk-Woo
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07): : 76B - 76B
12345